Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Coronary Obstruction Detection by Molecular Personalized Gene Expression (COMPASS)

This study has been completed.
Cardiovascular Research Foundation, New York
Piedmont Heart Institute, Inc., Atlanta, GA
Information provided by (Responsible Party):
CardioDx Identifier:
First received: May 3, 2010
Last updated: November 25, 2014
Last verified: November 2014